Oncology Venture Sweden AB

Not featured in screeners

Not featured in screeners

Top insiders

Download results Settings

Peter Buhl Jensen

CEO

1 sale — total 10,135,802 SEK

Sale 29 Jun 2018

Value SEK4,254,782.83 | Price 63.91 | Shares 99,937

Through a closely affiliated person

Peter Buhl Jensen

CEO

2 sales — total 7,957,595 SEK

Sale 1 Jun 2018

Value SEK143,841.29 | Price 24.75 | Shares 12,547

Through a closely affiliated person

Sale 1 Jun 2018

Value SEK1,193,530.75 | Price 252.92 | Shares 58,152

Through a closely affiliated person

Claus Frisenberg Pedersen

CFO

1 purchase — total 67,932 SEK

Buy 26 Mar 2018

Value SEK67,932.00 | Price 18.36 | Shares 3,700

Peter Buhl

1 purchase — total 3,022,430 SEK

Buy 17 Jan 2017

Value SEK3,022,430.00 | Price 10.00 | Shares 302,243

Through a closely affiliated person

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2018-07-05	2018-06-29	S Sale	Peter Buhl Jensen CEO Through a closely affiliated person	99,937 63.91 SEK4,254,783	99,937	63.91	SEK4,254,783
2018-06-04	2018-06-01	S Sale	Peter Buhl Jensen CEO Through a closely affiliated person	12,547 24.75 SEK143,841	12,547	24.75	SEK143,841
2018-06-04	2018-06-01	S Sale	Peter Buhl Jensen CEO Through a closely affiliated person	58,152 252.92 SEK1,193,531	58,152	252.92	SEK1,193,531
2018-03-28	2018-03-26	B Purchase	Claus Frisenberg Pedersen CFO	3,700 18.36 SEK67,932	3,700	18.36	SEK67,932
2017-01-25	2017-01-17	B Purchase	Peter Buhl VD Through a closely affiliated person	302,243 10.00 SEK3,022,430	302,243	10.00	SEK3,022,430

More insider trading research around Oncology Venture Sweden AB